证券记录 · 已归档季度
NVCR
Novocure Ltd · Healthcare · Medical - Devices
16被追踪持有人
+1Δ持有人
59.30M持有股份
$1.06B报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +6.7% ·
股份流向 +2.3% ·
净新建仓位 +6.2%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 119.64K | $1.43M | n/a | n/a |
| Q2 2026 | 91 | +1 | 75.35M | $1.14B | +7 | −6 |
| Q1 2026 | 93 | -1 | 69.74M | $759.20M | +6 | −7 |
| Q4 2025 | 93 | -2 | 74.88M | $967.62M | n/a | −2 |
| Q3 2025 | 19 | 0 | 56.46M | $729.50M | n/a | n/a |
| Q2 2025 | 16 | +1 | 59.30M | $1.06B | +2 | −1 |
| Q1 2025 | 12 | -3 | 16.40M | $292.30M | n/a | −3 |
| Q4 2024 | 15 | +1 | 16.08M | $479.25M | +1 | n/a |
| Q3 2024 | 13 | 0 | 14.54M | $227.34M | n/a | n/a |
| Q2 2024 | 13 | n/a | 14.57M | $249.63M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 16.72M | n/a | $297.67M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 2 | BlackRock ✦ (被动) | 14.11M | n/a | $251.24M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 3 | The Vanguard Group ✦ (被动) | 10.75M | n/a | $191.39M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | Capital World Investors ✦ | 6.38M | +22.4% | $113.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (被动) | 2.68M | +3.5% | $47.67M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (被动) | 2.44M | -0.8% | $43.52M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 1.41M | -21.7% | $25.18M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 1.30M | +69.1% | $23.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Baillie Gifford ✦ | 1.13M | -0.7% | $20.09M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 10 | Citadel Advisors ✦ | 894.15K | +178.8% | $15.92M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 646.78K | +17.3% | $11.51M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 12 | Point72 Asset Management ✦ | 470.00K | 新增 | $8.37M | 0.0% | New | 1 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 195.34K | -54.5% | $3.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 105.75K | -78.1% | $1.88M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 34.00K | +18.3% | $605,147 | 0.0% | ▲ Add | 5 | SEC ↗ ×5 |
| 16 | D. E. Shaw & Co. ✦ | 20.56K | 新增 | $365,897 | 0.0% | New | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $8.37M | 0.0% |
| D. E. Shaw & Co. | $365,897 | 0.0% |
已清仓
| Coatue Management | $10.85M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 221 持有人, 97.96M 股份, $1.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据